Reduction in the size of a hepatic haemangioma after chemotherapy.
Hashimoto
Manabu
M
Sugawara
Makoto
M
Ishiyama
Koichi
K
Sato
Tutomu
T
Yamamoto
Yuzo
Y
Nanjo
Hiroshi
H
D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001761:Bleomycin / Q000627:therapeutic use; D002945:Cisplatin / Q000627:therapeutic use; D003131:Combined Modality Therapy; D018240:Endodermal Sinus Tumor / Q000150:complications / Q000188:drug therapy*; D005047:Etoposide / Q000627:therapeutic use; D005260:Female; D006391:Hemangioma / Q000188:drug therapy* / Q000473:pathology / Q000601:surgery; D006801:Humans; D007044:Hysterectomy; D008113:Liver Neoplasms / Q000188:drug therapy* / Q000473:pathology / Q000601:surgery; D008279:Magnetic Resonance Imaging; D009378:Neoplasms, Multiple Primary; D010051:Ovarian Neoplasms / Q000150:complications / Q000188:drug therapy*; D014057:Tomography, X-Ray Computed; D016896:Treatment Outcome
D001761:Bleomycin; D005047:Etoposide; D002945:Cisplatin